- Telehealth Visits
- Insurance plan information
George F. Sawaya, MD
Obstetrics and Gynecology- Telehealth Visits
- Insurance plan information
George F. Sawaya, MD
Obstetrics and Gynecology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. George Sawaya is an obstetrician and gynecologist. He is the director of Zuckerberg San Francisco General Hospital and Trauma Center's cervical dysplasia clinic.
Sawaya's main research interest is in cervical cancer screening. He has specific interests in screening older women, issues of cost-effectiveness and cost-utility, and new approaches to population-based screening.
Sawaya earned his medical degree at the Vanderbilt University School of Medicine. He completed his residency in obstetrics and gynecology at UCSF, followed by a fellowship in the UCSF Department of Epidemiology and Biostatistics.
Sawaya is a lecturer as well as author or coauthor of book chapters and articles in peer-reviewed journals.
Education & training
Board certification
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Residency
- Gynecology, UCSF Medical Center House Staff
Internship
- Obstetrics, UCSF Medical Center House Staff
Degree
- MD, Vanderbilt University
My expertise
Locations
My research
Publications
Showing 1-6 of 47 reviews
- March 21, 20265 out of 5 Stars
Dr. Sawaya is one of the best care providers I have ever had on all facets.
- March 5, 20265 out of 5 Stars
Excellent! That's all I can say, excellent in everything!
- March 5, 20265 out of 5 Stars
Very gentle
- February 28, 20265 out of 5 Stars
Dr found ways from make my care more comfortable
- February 24, 20265 out of 5 Stars
Dr. Sawaya and his nurse were excellent.
- February 8, 20265 out of 5 Stars
Dr.Sawaya is an excellent doctor.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.